A decade after gene therapy, children born with deadly immune disorder remain healthy
Over a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder.They now report that the effects of the therapy appear to be long-lasting, with 90% of patients who received the treatment eight to 11 years ago still disease-free.ADA-SCID, oradenosine deaminase –deficient severe combined immunodeficiency, is caused by mutations in the gene that creates the ADA enzyme, which is essential to a functioning immune system. For babies with the disease, exposure to everyday germs can be fatal, and if untreated, most will die...
Source: UCLA Newsroom: Health Sciences - October 15, 2021 Category: Universities & Medical Training Source Type: news

Sharing Mayo Clinic: Diversity in bone marrow transplantation is gift of life for their mom
Only 20% of minorities are able to find a match when they require a transplant. But for one African American mom of five, finding that match meant the gift of life. _______________________________ Family is everything to Felicia Curtis. Family is the reason the mother of five from Gainesville, Florida, knew she had to fight when she was diagnosed with non-Hodgkin's lymphoma in 2017. She was 20 weeks pregnant with her youngest child. Over the next several months,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 26, 2021 Category: Databases & Libraries Source Type: news

Bone marrow transplant patients living longer, healthier, study finds
Bone marrow transplant recipients in the 2000s and 2010s are living longer, and with better overall health, than those who underwent the complex procedure in the 1970s, 1980s and 1990s, a JAMA Oncology study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 9, 2021 Category: Consumer Health News Source Type: news

Sharing Mayo Clinic: "Divine design" gives multiple myeloma patient transplant, care at home
Ann Arneson describes her journey to Mayo Clinic as “divine design.” Ann — a retired teacher, a leader in her church and ministry, mother, grandmother, and line dance enthusiast — is Mayo Clinic’s first bone marrow transplant patient to recover at home thanks to the new advanced care at home program. “I know that people and circumstances are not by chance, but for a purpose — part of a bigger plan,” says Ann. A brush… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 5, 2021 Category: Databases & Libraries Source Type: news

Paras Healthcare to foray in UP with over 400-bed hospital in Kanpur
Major focus of the hospital will be on providing treatment for oncology cardiology, neurology, gastroenterology, orthopaedic and renal sciences. It will also have a centre of excellence for kidney and bone marrow transplants, the statement said. (Source: The Economic Times)
Source: The Economic Times - August 16, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic Minute: Why bone marrow donor diversity is needed
Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people in need of a bone marrow transplant have to find a matching donor. Dr. Ernesto Ayala, a Mayo Clinic hematologist and oncologist, says bone marrow donations from people of all races and ethnicities are essential in order to help… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 8, 2021 Category: Databases & Libraries Source Type: news

The 10 Most Important Health Breakthroughs You Missed During the Pandemic
While most eyes were on COVID-19, researchers have also made groundbreaking advancements in other fields. Here’s a look. The other big vaccine news Public-health officials have long sought a vaccine against malaria, which infects up to 600 million people a year and kills 400,000, mostly children. This year, there was dramatic prog­ress toward that goal. In a study of 450 children in Burkina Faso, published in the Lancet in April, researchers reported that a new malaria vaccine, called R21, is 77% effective—just clearing the World Health Organization’s 75% efficacy standard. However, the sample gro...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Innovation Magazine Source Type: news

Finding New Optimism In Those Pandemic Babies
Well hello! I’m so glad you’re here. A version of this article also appeared in theIt’s Not Just You newsletter.Sign up here to receive a new edition every Sunday. As always, you can send comments to me at: Susanna@Time.com. A slew of beloved friends have been having babies lately. I’m embarrassingly emotional about their arrival, or even just the news that they’re on their way. Knowing that this new crop of young ones will uncover delight in this bruised world is one of those ancient wonders. [time-brightcove not-tgx=”true”] It’s been a fractious and scary year, but these p...
Source: TIME: Health - May 30, 2021 Category: Consumer Health News Authors: Susanna Schrobsdorff Tags: Uncategorized It's Not Just You Source Type: news

Innovative imaging technique for bone marrow transplants investigated
(University of Oklahoma) A hematology oncologist at OU Health Stephenson Cancer Center is the co-leader of a national clinical trial that could revolutionize the field of bone marrow transplant with an imaging technique that provides an early look at a transplant's likely success or failure. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 26, 2021 Category: Cancer & Oncology Source Type: news

Gene therapy offers potential cure to children born without an immune system
An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 children born with a rare and deadly inherited disorder that leaves them without an immune system.Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in theADA gene that creates the enzyme adenosine deaminase, which is essential to a functioning immune system.For children with the condition, even day-to-day activities like going to school or playing with friends can lead to dangerous, life-threatening infections...
Source: UCLA Newsroom: Health Sciences - May 11, 2021 Category: Universities & Medical Training Source Type: news

Science Saturday: Regenerative eyedrops tap blood for tears
Gregory Williams turned to regenerative medicine for healing after a one-two punch to his health. The 63-year-old Florida man survived?leukemia?only to develop ocular?graft-versus-host?disease, a potentially blinding complication of the bone marrow transplant that put his cancer in remission. Ocular graft-versus-host disease is a chronic debilitating condition with no cure that causes severe dry eyes. The?Regenerative [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 17, 2021 Category: Databases & Libraries Source Type: news

Low-calorie diet and mild exercise improve survival for young people with leukemia
In some cancers, including leukemia in children and adolescents, obesity can negatively affect survival outcomes. Obese young people with leukemia are 50% more likely to relapse after treatment than their lean counterparts.Now,a study led by researchers at UCLA and Children’s Hospital Los Angeles has shown that a combination of modest dietary changes and exercise can dramatically improve survival outcomes for those with acute lymphoblastic leukemia, the most common childhood cancer.The researchers found that patients who reduced their calorie intake by 10% or more and adopted a moderate exercise program imm...
Source: UCLA Newsroom: Health Sciences - April 1, 2021 Category: Universities & Medical Training Source Type: news

Obesity-Linked Gut Bacteria May Worsen Graft-Versus-Host Disease
Altered gut microbiome composition in obese mice and human patients is linked with severity of disease after bone marrow transplantation, a study found. (Source: The Scientist)
Source: The Scientist - April 1, 2021 Category: Science Tags: The Literature Magazine Issue Source Type: news

UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients ’ own blood-forming stem cells.The trial will combine CRISPR technology developed at the Innovative Genomics Institute — a UC Berkeley–UCSF initiative founded by Berkeley’s Nobel Prize–winning scientist Jennifer Doudna — with UCLA’s expertise in genetic analysis and cell manufacturing, and the decades-long expertise at U...
Source: UCLA Newsroom: Health Sciences - March 30, 2021 Category: Universities & Medical Training Source Type: news

A new, vital player in graft-versus-host disease and organ transplant rejection
(Michigan Medicine - University of Michigan) A long noncoding RNA whose function was previously unknown turns out to play a vital role in mobilizing the immune response following a bone marrow transplant or solid organ transplantation.The research, which included samples from more than 50 patients who underwent a bone marrow or heart transplant, suggests inhibiting the RNA therapeutically might improve outcomes for transplant recipients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2021 Category: Cancer & Oncology Source Type: news

Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units, Clinical Infectious Diseases 72: S1-S7
Conclusions Although prevalence was similar between the units, there were important differences in the rates of transmission and clearance. Influential factors may include antimicrobial exposure or other patient-care factors. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 19, 2021 Category: Consumer Health News Source Type: news

Jet It partners with Be The Match by donating flight time for bone marrow donations
Jet It, a private, fractional ownership private aviation firm headquartered in Greensboro, is employing its unique business model to assist patients in need of bone marrow transplants. Through its new partnership with Be The Match, Jet It, with its fleet of 10 HondaJets and growing, can provide a private air travel service for donors and life-saving donations for bone marrow transplants at a moment’s notice. Since April 2020, Be The Match and its partners have assisted with 36 donated private… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 23, 2020 Category: American Health Authors: Andy Warfield Source Type: news

Letters to the Editor: Wear a mask for 100 days? Cancer patients already do that
A reader says he had to wear a mask for 100 days after a bone marrow transplant, and he'll do it again to protect people from the coronavirus. (Source: L.A. Times - Health)
Source: L.A. Times - Health - December 8, 2020 Category: Consumer Health News Source Type: news

New method to boost supply of life-saving stem cells
(Center for Genomic Regulation) Researchers at the Centre for Genomic Regulation (CRG) in Barcelona and Columbia University in New York City have found a new method for growing a large quantity of life-saving blood stem cells. The scarcity of these cells is one of the greatest limitations for their use in a variety of medical procedures, from treatment of blood cancers to inherited blood disorders that require a bone marrow transplantation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2020 Category: Cancer & Oncology Source Type: news

Patti Payne: AML survivor returns home after bone marrow transplant, grateful for milestones
Now that Ryan Dwyer is home again, he is grateful and reflecting on that second difficult round of fighting leukemia which had returned with ferocity on May 20. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 25, 2020 Category: Health Management Authors: Patti Payne Source Type: news

Patti Payne: AML survivor returns home after bone marrow transplant, grateful for milestones
What ’s on your gratitude list for Thanksgiving and into the holidays? In the face of life-threatening challenges Ryan Dwyer, 40, is grateful for a long list of things. Gratitude is at the very fiber of his being. This Kenmore man just underwent a bone marrow transplant for acute myeloid leukemia — his second round of this aggressive disease. He thought he beat it the first time, but learned in mid-2020 it had returned with a vengeance, and thus the more drastic treatment was needed. Dwyer… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 25, 2020 Category: Biotechnology Authors: Patti Payne Source Type: news

EBMT 47th Annual Meeting
(European Society for Blood and Marrow Transplantation) The EBMT Annual Meeting is the most important annual event for research and education in the field of bone marrow transplantation and cellular therapy in Europe. It attracts more than 6,000 participants, including international experts, scientists, physicians, nurses, statisticians, clinical research technicians, patients and processing laboratory personnel. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 17, 2020 Category: Biology Source Type: news

Berlin patient: First person cured of HIV, Timothy Ray Brown, dies
Mr Brown, known as the Berlin patient, was cured after a bone marrow transplant to treat leukaemia. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 30, 2020 Category: Consumer Health News Source Type: news

Hugh Jackman Surprises 10-Year-Old And Bone Marrow Donor Who Saved Boy ’ s Life
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p3").init({"mcp":"cbs","width":"100%","height":"100%","video":"4738529","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p3","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 25, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Bone Marrow Donation Grady Smith Hugh Jackman Jessica Carroll. Source Type: news

A Woman May Have Been Cured of H.I.V. Without Medical Treatment
In dozens of other patients who suppress the virus without drugs, it seems to have been cornered in parts of the genome where it cannot reproduce, scientists reported. (Source: NYT Health)
Source: NYT Health - August 26, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Acquired Immune Deficiency Syndrome Genetics and Heredity Immune System Bone Marrow Transplants your-feed-science Nature (Journal) Harvard University Source Type: news

UArizona Health Sciences researcher seeks safer, more effective leukemia treatment
(University of Arizona Health Sciences) A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences. The procedure is known as a haploidentical (half-matched) bone marrow transplantation, or " haplo-BMT, " providng an alternate source of stem cells for patients needing a bone marrow transplant but unable to find a perfect or near-perfect donor match for human leukocyte antigens. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 3, 2020 Category: Cancer & Oncology Source Type: news

Two Cohrane Croatia members receive awards from the city of Split for 2019
Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, and Matko Marušić, head of quality assurance at Cochrane Croatia, both received awards from the city of Split.  The Split City Council, on May 4, 2020, decided that the traditional awards of the city of Split should be given to two members of theCochrane  Croatia. The personal award was given to Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, for selfless commitment and work on the popularization of breastfeeding. A second award was given to Matko Marušić, head of quality assurance at Cochrane Croatia, for the boo...
Source: Cochrane News and Events - July 8, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Two Cochrane Croatia members receive awards from the city of Split for 2019
Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, and Matko Marušić, head of quality assurance at Cochrane Croatia, both received awards from the city of Split.  The Split City Council, on May 4, 2020, decided that the traditional awards of the city of Split should be given to two members of theCochrane  Croatia. The personal award was given to Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, for selfless commitment and work on the popularization of breastfeeding. A second award was given to Matko Marušić, head of quality assurance at Cochrane Croatia, for the boo...
Source: Cochrane News and Events - July 8, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

More Covid-19 guidelines from NICE
NICE has published more “rapid” guidelines, this time covering provision of radiotherapy services and bone marrow transplant during the Covid-19 pandemic. (Source: NHS Networks)
Source: NHS Networks - April 1, 2020 Category: UK Health Source Type: news

Evolving HTA frameworks to accelerate innovation
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.    To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 confere...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Evolving HTA frameworks to accelerate innovation
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.    To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 confere...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Second person cleared of HIV remains free of virus one year on
Researchers reveal Adam Castillejo still in remission 12 months after ‘cure’ declaredThe patient who became the second person ever to be cleared of HIV remains free of the virus a year after initial reports of a “cure”, researchers have revealed.Adam Castillejo, who wasuntil Monday known only as the “London patient”,wasdeclared free of HIV last year, 18 months after stopping antiretroviral therapy following a stem cell, or bone marrow, transplant to treat a type of blood cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 10, 2020 Category: Science Authors: Nicola Davis Tags: Aids and HIV Medical research Science London UK news Health Society Source Type: news

The 'London patient' who was CURED of HIV reveals his identity
Adam Castillejo, 40, was known only as the 'London patient' until today. He was anonymised by doctors who revealed he had been cured of HIV after having a bone marrow transplant for blood cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2020 Category: Consumer Health News Source Type: news

Tanzania: Hospital Gets Set for Bone Marrow Feat
[Daily News] MUHIMBILI National Hospital (MNH) is finalising procedures for embarking on bone marrow transplants by the end of March this year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 22, 2020 Category: African Health Source Type: news

What Conditions Do You Need a Bone Marrow Transplant for?
Title: What Conditions Do You Need a Bone Marrow Transplant for?Category: Diseases and ConditionsCreated: 2/20/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 20, 2020 Category: Cancer & Oncology Source Type: news

Bone Marrow Transplant Risks and Survival Rate
Title: Bone Marrow Transplant Risks and Survival RateCategory: Diseases and ConditionsCreated: 2/20/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 20, 2020 Category: Cancer & Oncology Source Type: news

Outcomes After Bone Marrow Transplants Continue to Improve Outcomes After Bone Marrow Transplants Continue to Improve
The downward trajectory in mortality rates first documented in the early 2000s continues among bone marrow transplant recipients due to small, additive steps that collectively have improved outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Bone Marrow Transplants Less Risky Now
Title: Bone Marrow Transplants Less Risky NowCategory: Health NewsCreated: 1/29/2020 12:00:00 AMLast Editorial Review: 1/30/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 30, 2020 Category: Cancer & Oncology Source Type: news

Bone Marrow Transplants Less Risky Now
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 29, 2020 Category: Cancer & Oncology Tags: Family Medicine, Nursing, Oncology, Organ Transplants, News, Source Type: news

Bone Marrow Transplants Less Risky Now
WEDNESDAY, Jan. 29, 2020 -- The risks faced by U.S. bone marrow transplant patients have dropped sharply, a new study shows. While this type of transplant can be lifesaving for patients with blood cancers (such as leukemia) and other diseases,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 29, 2020 Category: General Medicine Source Type: news

Six patients with rare blood disease are doing well after gene therapy clinical trial
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD. Six of those patients are now in remission and have stopped other treatments. Before now, people with X-CGD – which causes recurrent infections, prolonged hospitalizations for treatment, and a shortened lifespan – had to rely on bone marrow donations for a chance at remission.“With this gene therapy, you can use a patient’s own stem cells instead of donor cells for a transplant,&rdqu...
Source: UCLA Newsroom: Health Sciences - January 28, 2020 Category: Universities & Medical Training Source Type: news

Big gains in bone marrow transplant survival since mid-2000s
(Fred Hutchinson Cancer Research Center) A bone marrow transplant can be a lifesaving treatment, but it can come with life-threatening risks. The encouraging news for patients: Those risks have been plummeting for years. The overall risk of death after transplant dropped 34% between 2003-2007 and 2013-2017, according to an analysis published in the Jan. 21 issue of the Annals of Internal Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 20, 2020 Category: International Medicine & Public Health Source Type: news

Blood stem cell research
(University of Delaware) A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware's Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body. Her work has been recognized with an award from the University City Science Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news

Eligible for two schemes but these patients still can't get money for transplants
Eleven-year-old Sameer from Bihar ’s Muzaffarpur district is suffering from aplastic anaemia, and needs Rs 12 lakh for a bone marrow transplant. You would think that’s not a big hurdle since his mother’s name figures in the list of Ayushman Bharat beneficiaries but unfortunately his condition isn’t covered by the scheme. (Source: The Economic Times)
Source: The Economic Times - December 21, 2019 Category: Consumer Health News Source Type: news

Medical doctors STUNNED as bone marrow transplant for leukemia treatment changes man’s DNA, proving medical interventions can OVERWRITE your genetic code
(Natural News) A Nevada man was shocked to learn that a bone marrow transplant he received actually changed his DNA and replaced it with that of his German donor. Chris Long of Reno is currently in remission from acute myeloid leukemia. Three months after his bone marrow transplant operation, he discovered that the DNA in... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2019 Category: Consumer Health News Source Type: news

Jefferson, Temple sign definitive agreement for sale of Fox Chase Cancer Center
Thomas Jefferson University entered into a binding agreement Wednesday with Temple University under which Jefferson will acquire Fox Chase Cancer Center and Temple's bone marrow transplant program. The deal, which will require regulatory approvals, doesn't end there. Jefferson and Temple, which reached a preliminary deal back in July, said they also plan to collaborate in a variety of areas including cancer research and treatment, caring for the underserved, driving innovation, and increasi ng educational… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 18, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Heart and lung transplant patients celebrate the gift of life
Esteban Jaramillo, 38, received a double lung transplant at Ronald Reagan UCLA Medical Center this past August after both of his lungs collapsed. He had faced health challenges in the past, having undergone a bone marrow transplant 14 years ago, but he didn ’t expect to develop a lung condition as well. Despite these hardships, Jaramillo remained hopeful.“Since I was a kid my grandma told me to have a lot of faith,” he said. “UCLA is a place where miracles of science really happen. I got my life back here.”Jaramillo ’s success story is one of many that were celebrated recently at the UCL...
Source: UCLA Newsroom: Health Sciences - December 17, 2019 Category: Universities & Medical Training Source Type: news

The Case of a Man With Two Sets of DNA Raises More Questions
A crime lab studied a patient ’s response to a bone marrow transplant. Readers requested more information about the perplexing findings. (Source: NYT Health)
Source: NYT Health - December 12, 2019 Category: Consumer Health News Authors: Heather Murphy Tags: Bone Marrow Forensic Science DNA (Deoxyribonucleic Acid) Sperm Transplants Coop, Graham Source Type: news

Nigeria: Nigerian Reseacher Flays Promotion of Bone Marrow Transplant for HIV/Aids Cure
[Vanguard] A Nigerian researcher, Prof. Maduike Ezeibe, has frowned at the analytical treatment interruption, otherwise known as bone marrow transplant, being promoted as cure for HIV/AIDS. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - December 12, 2019 Category: Infectious Diseases Source Type: news